Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |